Global Fund approves 'in principle' $47M grant for reducing spread of HIV among MSM, transgender in South Asia

NewsGuard 100/100 Score

The Global Fund to Fight AIDS, Tuberculosis and Malaria has approved, "in principle," a $47 million grant to reduce the spread of HIV among gay and other men who have sex with men in seven south Asian countries, IANS/Thaindian.com reports. According to a statement IANS/Thaindian.com reports was released by the Global Fund, in New Delhi, "This [project] marks the first time, the Global Fund will support a major regional project in Asia specifically addressing men who have sex with men (MSM), transgenders and HIV." 

Shivananda Khan, of Naz Foundation International (NFI), one of the NGOs that will be involved in the program said, "The grant provides South Asia with a promising platform which must continue to be strengthened by all concerned - governments, international development partners and community partners alike."

According to IANS/Thaindia, NFI along with Population Services International, the United Nations Development Program's regional centre in Colombo and the South Asian MSM and AIDS Network (SAMAN), "had approached the Global Fund on this matter" (11/25).

According to Xinhua, the project will target the countries of Afghanistan, Bangladesh, Bhutan, India, Nepal, Pakistan and Sri Lanka. "Millions of gay and transgender people in South Asia suffer from discrimination in many aspects of their day to day lives. This makes them more vulnerable to HIV and undermines their capacity to contribute fully to their communities and societies," said Jeffrey O'Malley, Global Director of UNDP's HIV Group. "This grant reflects the commitment of the international community to support the health and human rights of all people, even the most marginalized," he added (11/25).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New drug candidates show promise to reverse HIV immune evasion